Mayzent 0.25 mg, 1 mg, 2 mg film-coated tablets
*Company:
Novartis Ireland LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 01 May 2025
File name
Mayzent_REG SPC_PF25-0103_27.03.2025_clean.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 January 2025
File name
Mayzent REGSPC PF25-0014 clean Jan 2025.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 January 2025
File name
Mayzent_REGPIL_R89_PF25-0014 Clean tbi by 03.06.2025.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 20 January 2025
File name
Mayzent REGSPC PF25-0014 clean Jan 2024.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 September 2024
File name
Mayzent_REG PIL_PF24-0184_19.09.2024_clean_Barcelona.pdf
Reasons for updating
- Removal of Black Inverted Triangle
Updated on 27 September 2024
File name
Mayzent REGSPC PF24-0184 clean September 2024.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Removal of Black Inverted Triangle
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
Mayzent_PregnancyReminderCard_AUG23_RMPv6.1.pdf
Reasons for updating
- Add New Doc
Updated on 17 May 2024
File name
Mayzent REGSPC PF24-0097_May 2024_Clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
Mayzent_HCP_Checklist_AUG23_RMPv6.1.pdf
Reasons for updating
- Replace File
File name
Mayzent_Patient_CaregiverGuide_AUG23_RMPv6.1.pdf
Reasons for updating
- Add New Doc
File name
Mayzent_PregnancyReminderCard_AUG23_RMPv6.1.pdf
Reasons for updating
- Add New Doc
File name
12532_Mayzent_HCP_Checklist_AUG23_LR3.pdf
Reasons for updating
- Add New Doc
File name
12532_Mayzent_HCP_Checklist_AUG23_LR3.pdf
Reasons for updating
- Add New Doc
File name
12836_Mayzent_Patient_CaregiverGuide_AUG23_LR4.pdf
Reasons for updating
- Add New Doc
File name
12836_Mayzent_PregnancyReminderCard_AUG23_LR1.pdf
Reasons for updating
- Add New Doc
Updated on 07 February 2024
File name
Mayzent REGPIL PF24-0004 clean Jan 2024.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 23 January 2024
File name
Mayzent REGSPC PF24-0011 Jan 2024_Clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 10 January 2024
File name
Mayzent REGPIL PF24-0004 clean Jan 2024.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 10 January 2024
File name
MAYZENT REGSPC PF24-0004_Jan 24_Clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 18 August 2023
File name
Mayzent_REG PIL_PF23-0144_06.07.2023_clean_Nürnberg .pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 18 August 2023
File name
Mayzent_REG SPC_PF23-0144_06.07.2023_clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
12532_Mayzent_RMP_Patient-CaregiverReminderCard_SEPT22_LR2.pdf
Reasons for updating
- Add New Doc
File name
12532_Mayzent_HCP_Checklist_SEPT22_LR4.pdf
Reasons for updating
- Add New Doc
Free text change information supplied by the pharmaceutical company
HCP
Updated on 22 February 2023
File name
Mayzent FCT REGSPC PF 23-0016_Jan 2023 Clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 18 January 2023
File name
Mayzent REGPIL PF23-0016 Clean 12 Jan 2023.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 18 January 2023
File name
Mayzent FCT REGSPC PF 23-0016_Jan 2023 Clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 July 2022
File name
Mayzent all doses PIL R89 PF22-0135 clean 18.07.2022.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 26 July 2022
File name
Mayzent_REG SPC_PF22-0135_18.07.2022_clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 February 2022
File name
Mayzent REGPIL PF22-0047_Feb-22_Clean.pdf
Reasons for updating
- Introduction of new pack/pack size
Updated on 24 February 2022
File name
Mayzent REGSPC PF22-0047_Feb-22_Clean.pdf
Reasons for updating
- Other
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 January 2022
File name
MAYZENT_REGSPC PF 21-0319_Nov 2021_Clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 January 2022
File name
Mayzent REGPIL PF 21-0291 10.2021_Clean.pdf
Reasons for updating
- New PIL for new product
Novartis Ireland Limited
Address:
Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, IrelandMedical Information E-mail:
medinfo.dublin@novartis.comTelephone:
+353 1 2601255Fax:
+353 1 2601263